COL9A3 Gene Epiphyseal Dysplasia Multiple Type 3 Genetic Test
Welcome to DNA Labs UAE, where we offer the COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test. This test is designed to analyze the DNA sequence of the COL9A3 gene and identify any mutations or variations that may be present.
Test Details
The COL9A3 gene is associated with a rare genetic disorder called epiphyseal dysplasia, multiple, type 3. This condition affects the development of the bones and joints, particularly the growth plates (epiphyses) at the ends of long bones. Individuals with this disorder may experience symptoms such as short stature, joint pain and stiffness, and early-onset osteoarthritis. Other skeletal abnormalities, such as scoliosis or platyspondyly, may also be present.
Test Components and Price
The COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test is priced at 4400.0 AED. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
Once the sample is received, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next Generation Sequencing) technology, which allows for a comprehensive analysis of the COL9A3 gene.
Test Type and Doctor
The COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test falls under the category of Osteology Dermatology Immunology Disorders. The test is conducted by a dermatologist in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the COL9A3 Gene Epiphyseal dysplasia multiple type 3 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by this condition.
Importance of Test Results
The results of this genetic test can help confirm a diagnosis, understand the inheritance pattern of the condition, and provide information for genetic counseling. It is crucial to have the test performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can offer guidance on the appropriateness of testing, the implications of the results, and any potential treatment or management options available for individuals with epiphyseal dysplasia, multiple, type 3.
| Test Name | COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for COL9A3 Gene Epiphyseal dysplasia, multiple, type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL9A3 Gene Epiphyseal dysplasia, multiple, type 3 NGS Genetic DNA Test gene COL9A3 |
| Test Details |
The COL9A3 gene is associated with a condition called epiphyseal dysplasia, multiple, type 3. This genetic test, known as NGS (Next Generation Sequencing), is used to analyze the DNA sequence of the COL9A3 gene to identify any mutations or variations that may be present. Epiphyseal dysplasia, multiple, type 3 is a rare genetic disorder that affects the development of the bones and joints, particularly the growth plates (epiphyses) at the ends of long bones. It is characterized by short stature, joint pain and stiffness, and early-onset osteoarthritis. Other skeletal abnormalities may also be present, such as abnormal curvature of the spine (scoliosis) or flattened vertebrae (platyspondyly). NGS genetic testing allows for a comprehensive analysis of the COL9A3 gene, identifying any specific mutations or variations that may be responsible for the development of epiphyseal dysplasia, multiple, type 3. This information can be helpful in confirming a diagnosis, understanding the inheritance pattern of the condition, and providing information for genetic counseling. It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor. They can provide guidance on the appropriateness of testing, the implications of the results, and any potential treatment or management options available for individuals with epiphyseal dysplasia, multiple, type 3. |
